Regulation of HIV Transcription Elongation
HIV转录延伸的调控
基本信息
- 批准号:7685816
- 负责人:
- 金额:$ 41.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-19 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:BindingBiochemicalBudgetsCell LineCellsChromatinComplexCoupledDataDrug resistanceEventFutureGenesGenetic TranscriptionGoalsHIVHIV InfectionsHistone AcetylationHistone DeacetylaseHistonesHuman ResourcesIn VitroMaintenanceMass Spectrum AnalysisMolecularNucleosomesPolymerasePopulationPositioning AttributePositive Transcriptional Elongation Factor BPrintingProcessProvirusesRNA Polymerase IIRegulationReportingSiteSmall Interfering RNASuggestionSystemTranscription ElongationTranscription InitiationViralViral PhysiologyVirusbasecellular targetingchromatin immunoprecipitationchromatin remodelingfoothistone modificationin vivoinhibitor/antagonistinsightnegative elongation factornovelpermanganateprematurepublic health relevancepurgeresistant straintermination factortranscription factortranscription termination
项目摘要
DESCRIPTION (provided by applicant): Studies of the molecular events that establish and maintain latency have been hampered by the rarity and inaccessibility of latently infected cells. HIV provirus is regulated at the level of transcription and involves changes in transcription initiation, chromatin organization and elongation. In particular, transcription elongation has been demonstrated to be a limiting step for HIV expression and overcoming this block is the primary activity of the viral factor Tat. We hypothesize that cellular factors that regulate transcription elongation and premature transcription termination have a direct impact on HIV transcription, including extinguishing HIV transcription and establishing latency. Preliminary data show that Pol II processivity is a check point for HIV transcription in the absence of Tat and that two factors, NELF and Pcf11, negatively regulate HIV transcription elongation. Using a variety of biochemical approaches, including chromatin immunoprecipitation, Pol II foot printing and in vivo and in vitro transcription systems, we propose to determine the biochemical mechanisms and characterize the cellular factors that negatively regulate HIV transcription elongation. We expect that these studies will provide new insights into the establishment, maintenance and reversal of HIV latency. Understanding the regulation of HIV transcription elongation will provide novel cellular targets for controlling and purging HIV in different cellular reservoirs. PUBLIC HEALTH RELEVANCE: Successfully eradicating HIV infection will require understanding how cellular reservoirs that poorly express virus are established and maintained as well as determining whether these populations can be purged of HIV. This proposal focuses on the biochemical mechanisms that repress HIV transcription, in order to gain insights into factors that regulate HIV latency with long term goals of identifying novel targets for controlling HIV expression in different cells.
描述(由申请人提供):对建立和维持潜伏期的分子事件的研究因潜伏感染细胞的稀有性和不可接近性而受到阻碍。 HIV原病毒在转录水平受到调节,涉及转录起始、染色质组织和延伸的变化。特别是,转录延伸已被证明是 HIV 表达的限制步骤,克服这一阻碍是病毒因子 Tat 的主要活性。我们假设调节转录延伸和过早转录终止的细胞因素对 HIV 转录有直接影响,包括消除 HIV 转录和建立潜伏期。初步数据表明,在没有 Tat 的情况下,Pol II 持续性是 HIV 转录的检查点,并且 NELF 和 Pcf11 这两个因素负向调节 HIV 转录延伸。使用多种生化方法,包括染色质免疫沉淀、Pol II 足印以及体内和体外转录系统,我们建议确定生化机制并表征负调节 HIV 转录延伸的细胞因子。我们期望这些研究将为艾滋病毒潜伏期的建立、维持和逆转提供新的见解。了解 HIV 转录延伸的调节将为控制和清除不同细胞库中的 HIV 提供新的细胞靶标。公共卫生相关性:成功根除艾滋病毒感染需要了解病毒表达不良的细胞储存库是如何建立和维持的,以及确定是否可以清除这些人群中的艾滋病毒。该提案重点关注抑制 HIV 转录的生化机制,以便深入了解调节 HIV 潜伏期的因素,长期目标是确定控制不同细胞中 HIV 表达的新靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew J Henderson其他文献
Andrew J Henderson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew J Henderson', 18)}}的其他基金
Signals that establish and maintain HIV latency
建立和维持 HIV 潜伏期的信号
- 批准号:
10394879 - 财政年份:2018
- 资助金额:
$ 41.62万 - 项目类别:
Signals that establish and maintain HIV latency
建立和维持 HIV 潜伏期的信号
- 批准号:
9906842 - 财政年份:2018
- 资助金额:
$ 41.62万 - 项目类别:
Transcription mechanisms that contribute to HIV-1 latency
导致 HIV-1 潜伏期的转录机制
- 批准号:
8468555 - 财政年份:2013
- 资助金额:
$ 41.62万 - 项目类别:
Transcription mechanisms that contribute to HIV-1 latency
导致 HIV-1 潜伏期的转录机制
- 批准号:
8637913 - 财政年份:2013
- 资助金额:
$ 41.62万 - 项目类别:
Transcriptional mechanisms that contribute to HIV-1 latency
导致 HIV-1 潜伏期的转录机制
- 批准号:
8299328 - 财政年份:2011
- 资助金额:
$ 41.62万 - 项目类别:
Regulation of HIV by T-Cell Signal Transduction
T 细胞信号转导对 HIV 的调节
- 批准号:
7869139 - 财政年份:2009
- 资助金额:
$ 41.62万 - 项目类别:
Regulation of HIV by T-Cell Signal Transduction
T 细胞信号转导对 HIV 的调节
- 批准号:
7060900 - 财政年份:2005
- 资助金额:
$ 41.62万 - 项目类别:
Regulation of HIV by T-Cell Signal Transduction
T 细胞信号转导对 HIV 的调节
- 批准号:
7347014 - 财政年份:2005
- 资助金额:
$ 41.62万 - 项目类别:
相似海外基金
CAREER: Biochemical and Structural Mechanisms Controlling tRNA-Modifying Metalloenzymes
职业:控制 tRNA 修饰金属酶的生化和结构机制
- 批准号:
2339759 - 财政年份:2024
- 资助金额:
$ 41.62万 - 项目类别:
Continuing Grant
Systematic manipulation of tau protein aggregation: bridging biochemical and pathological properties
tau 蛋白聚集的系统操作:桥接生化和病理特性
- 批准号:
479334 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Operating Grants
Diurnal environmental adaptation via circadian transcriptional control based on a biochemical oscillator
基于生化振荡器的昼夜节律转录控制的昼夜环境适应
- 批准号:
23H02481 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Leveraging releasable aryl diazonium ions to probe biochemical systems
利用可释放的芳基重氮离子探测生化系统
- 批准号:
2320160 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Standard Grant
Biochemical Mechanisms for Sustained Humoral Immunity
持续体液免疫的生化机制
- 批准号:
10637251 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Structural and biochemical investigations into the mechanism and evolution of soluble guanylate cyclase regulation
可溶性鸟苷酸环化酶调节机制和进化的结构和生化研究
- 批准号:
10604822 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Enhanced Biochemical Monitoring for Aortic Aneurysm Disease
加强主动脉瘤疾病的生化监测
- 批准号:
10716621 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Converting cytoskeletal forces into biochemical signals
将细胞骨架力转化为生化信号
- 批准号:
10655891 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Chemical strategies to investigate biochemical crosstalk in human chromatin
研究人类染色质生化串扰的化学策略
- 批准号:
10621634 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
EAGER: Elastic Electronics for Sensing Gut Luminal and Serosal Biochemical Release
EAGER:用于感测肠腔和浆膜生化释放的弹性电子器件
- 批准号:
2334134 - 财政年份:2023
- 资助金额:
$ 41.62万 - 项目类别:
Standard Grant














{{item.name}}会员




